Wegovy Prescription Levels: What the Dose Schedule Actually Means

Wegovy has five main titration steps: 0.25mg, 0.5mg, 1.0mg, 1.7mg, and 2.4mg — with 7.2mg now available as the highest licensed maintenance dose following MHRA approval in April 2026.
Each level is held for approximately four weeks before a prescriber considers increasing it; the lower doses are tolerance-building steps, not therapeutic targets.
The 7.2mg single-dose pen was approved for adults with a BMI of 30 or above; eligibility for this level is confirmed through a clinical assessment, not assumed.
If you experience side effects that don't settle, your prescriber may keep you at a lower level longer or pause titration, this is normal clinical practice, not a setback.

Wegovy is prescribed at increasing dose levels over several months, starting at 0.25mg and rising to either 2.4mg or the newer 7.2mg maintenance dose — a once-weekly subcutaneous injection, titrated step by step by a prescriber based on your tolerance and progress. It is a prescription-only medicine; a clinician assesses suitability before any dose is issued or changed. If you've just been told you're being moved up a level, or you're trying to understand what to expect at each stage, the picture below should help.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How Wegovy Dose Levels Work in Practice, and What Shapes Yours

You've started on 0.25mg and wondered whether that's really doing anything

Almost everyone on Wegovy begins at the lowest level. The first pen isn't there to drive weight loss; its job is to let your gut adapt to semaglutide before the dose climbs. Nausea is the most common reason people stop GLP-1 treatment early, and the slow-start schedule exists specifically to reduce that risk. Four weeks at 0.25mg, four weeks at 0.5mg, and so on, the body generally tolerates the next level better because the previous one has already changed how your stomach empties and how your brain reads hunger signals. If you're feeling impatient at week two, that's understandable. Most people describe the early weeks as anticlimactic. But clinical experience is consistent on this: rushing the schedule trades short-term satisfaction for a much harder time later. Your prescriber sets the pace, and a pharmacist or prescriber can answer specific questions about what your current level should feel like. If you want to understand how a Wegovy prescription works and what the titration process looks like from the start, that page covers what to expect alongside how the medicine works during titration.

The difference between a titration dose and a maintenance dose on the Wegovy schedule

The five main levels split broadly into two groups. Doses up to 1.0mg are stepping stones; 1.7mg and 2.4mg are where most people stay long term, with 2.4mg the standard maintenance dose in clinical trials. In the STEP 1 trial, published in the New England Journal of Medicine, participants on 2.4mg achieved an average body-weight reduction of around 15% over 68 weeks alongside lifestyle changes. In April 2026, the MHRA approved a dedicated single-dose 7.2mg pen (one pre-set weekly injection) for adults with obesity (BMI of 30 or above). Trials at this higher level reported average weight loss of around 20.7% over 72 weeks, approaching results seen with tirzepatide at its highest doses. The 7.2mg level is the maximum; it is reached via the same step-by-step titration from 0.25mg. Jumping directly to a higher maintenance level is not how this medicine works. If you're comparing what different prescription levels might mean for your own situation, the Wegovy cost context page is worth reading alongside this one, prescription level affects how much you'll pay privately each month.

What actually determines which level you're prescribed, and when it changes

Prescribers consider several things when deciding whether to move someone to the next level: how well the current dose is tolerated, what side effects (if any) are present, and whether weight loss is progressing as expected. NICE guidance on semaglutide, published as TA875, notes that if someone has achieved less than 5% weight loss after six months on the maintenance dose, continuing treatment should be reconsidered, which is a useful marker for understanding what the upper levels are meant to deliver. In practice, some people stay at 1.7mg if 2.4mg causes side effects that don't settle. Others move through the schedule faster if tolerance is good. Neither path is wrong. What matters is that a real clinician is reviewing the picture, at nume, every repeat order is looked at by a GPhC-registered prescriber before anything is dispensed, and dose increases require clinical evidence rather than simply being requested. If you're unsure whether your current level is right, the process for getting a Wegovy prescription reviewed explains what that assessment involves.

What changes at each new prescription level, and what to watch for

Each step up typically brings a short recurrence of GI side effects (nausea, loose stools, or a change in appetite) as the body adjusts again. These usually settle within a week or two. The NHS semaglutide page lists the common side effects clearly and is worth bookmarking for reference. More serious symptoms (severe, persistent stomach pain that spreads toward the back, signs of an allergic reaction, or mood changes) need prompt medical attention and should not be attributed to dose adjustment without speaking to a clinician. Yellow Card reporting at yellowcard.mhra.gov.uk is the right route for any suspected serious reaction. The key thing to understand about dose levels is that they are not a ladder to climb as quickly as possible. Each one is a calibrated step, set by regulation and refined by clinical trial data. If you're thinking about starting Wegovy and want to understand how getting a Wegovy prescription online works, or want to know what separates a legitimate route from non-prescription Wegovy sources, speaking to our prescribers is the place to begin.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions